These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36583943)

  • 1. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
    Useini L; Mojić M; Laube M; Lönnecke P; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2023 Mar; 18(5):e202200583. PubMed ID: 36583943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carborane Conjugates with Ibuprofen, Fenoprofen and Flurbiprofen: Synthesis, Characterization, COX Inhibition Potential and In Vitro Activity.
    Sonam S; Jelača S; Laube M; Schädlich J; Pietzsch J; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN; Hey-Hawkins E
    ChemMedChem; 2024 Jun; ():e202400018. PubMed ID: 38844420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
    Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboranyl Analogues of Mefenamic Acid and Their Biological Evaluation.
    Useini L; Mojić M; Laube M; Lönnecke P; Dahme J; Sárosi MB; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
    ACS Omega; 2022 Jul; 7(28):24282-24291. PubMed ID: 35874202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.
    Brogden RN; Pinder RM; Speight TM; Avery GS
    Drugs; 1977 Apr; 13(4):241-65. PubMed ID: 324748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
    Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of aspirin-like drugs.
    Vane JR; Botting RM
    Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):2-10. PubMed ID: 9219313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs.
    Urban MK
    Orthopedics; 2000 Jul; 23(7 Suppl):S761-4. PubMed ID: 10914695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond.
    Rao P; Knaus EE
    J Pharm Pharm Sci; 2008 Sep; 11(2):81s-110s. PubMed ID: 19203472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
    Blain H; Jouzeau JY; Netter P; Jeandel C
    Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
    Dammann HG
    Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New drugs for the treatment of rheumatoid arthritis.
    Schuna AA; Megeff C
    Am J Health Syst Pharm; 2000 Feb; 57(3):225-34. PubMed ID: 10674776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of cyclooxygenase and prostaglandins in the pathogenesis of rheumatoid arthritis].
    Stańczyk J; Kowalski ML
    Pol Merkur Lekarski; 2001 Nov; 11(65):438-43. PubMed ID: 11852819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC
    Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory drugs in the 21st century.
    Rainsford KD
    Subcell Biochem; 2007; 42():3-27. PubMed ID: 17612044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.